<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001104659-25-049481</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: BAKER BROS. ADVISORS LP -->
          <cik>0001263508</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common Stock, par value $0.000001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001404644</issuerCik>
        <issuerName>Neurogene Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>64135M105</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>535 W 24th Street, 5th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10011</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Baker Bros. Advisors LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1034522.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1034522.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1034522.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.99</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Baker Bros. Advisors (GP) LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1034522.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1034522.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1034522.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.99</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Julian C. Baker</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1034635.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1034635.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1034635.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.99</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Felix J. Baker</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1034635.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1034635.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1034635.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>4.99</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Neurogene Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>535 W 24th Street, 5th Floor New York, NY 10011</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Amendment No. 2 is being filed by Baker Bros. Advisors LP (the "Adviser"), Baker Bros. Advisors (GP) LLC (the "Adviser GP"), Julian C. Baker and Felix J. Baker (collectively, the "Reporting Persons"). Except as supplemented herein, such statements, as heretofore amended and supplemented, remain in full force and effect. This Amendment No. 2 is being filed jointly by the Reporting Persons.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The business address of each of the Reporting Persons is:
 c/o Baker Bros. Advisors LP
 860 Washington Street, 3rd Floor
 New York, NY 10014
 (212) 339-5690</principalBusinessOfficeOrResidenceAddress>
        <citizenship>The Adviser is a limited partnership organized under the laws of the State of Delaware. The Adviser GP is a limited liability company organized under the laws of the State of Delaware. The citizenship of each of Julian C. Baker and Felix J. Baker is the United States of America.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Items 5 through 9 of each of the cover pages to this Amendment No. 2 are incorporated herein by reference. Set forth below is the aggregate number of shares of common stock ("Common Stock") of Neurogene Inc. (the "Issuer") directly held in the aggregate by Baker Brothers Life Sciences, L.P. ("Life Sciences") and 667, L.P. ("667", and together with Life Sciences, the "Funds") which may be deemed to be indirectly beneficially owned by the Reporting Persons, plus 2,500 shares of Common Stock directly held by M. Cantey Boyd, an employee of the Adviser, which shares were received from the exercise of options to purchase Common Stock of the Issuer ("Stock Options") received as director's compensation for her previous service on the board of directors of the Issuer (the "Board") as well as shares of Common Stock that may be acquired upon exercise of prefunded warrants with no expiration date exercisable at any time for Common Stock on a 1-for-1 basis at an exercise price of $0.000001 per share, subject to limitations on exercise described below ("$0.000001 Prefunded Warrants"), prefunded warrants with no expiration date exercisable at any time for Common Stock on a 1-for-1 basis at an exercise price of $0.00002 per share, subject to limitations on exercise described below ("$0.00002 Prefunded Warrants") and prefunded warrants with no expiration date exercisable at any time for Common Stock on a 1-for-1 basis at an exercise price of $0.001 per share, subject to limitations on exercise described below ("$0.001 Prefunded Warrants" and together with $0.000001 Prefunded Warrants and $0.00002 Prefunded Warrants, the "Prefunded Warrants"). The Reporting Persons each beneficially own 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise described below. In addition to the above, Julian C. Baker and Felix J. Baker each also directly hold 113 shares of Common Stock of the Issuer previously received from in-kind distributions.

The Adviser and the Adviser GP beneficially own 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described below as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd.

Julian C. Baker and Felix J. Baker beneficially own 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described below as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd and 113 shares of Common Stock directly held by each of Julian C. Baker and Felix J. Baker.

The Prefunded Warrants are only exercisable to the extent that upon giving effect or immediately prior to such exercise the holders thereof, together with their affiliates and any members of a Section 13(d) group with such holders and/or their affiliates would beneficially own, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), no more than 4.99% of the outstanding shares of Common Stock (the "Maximum Percentage"). By written notice to the Issuer, the Funds may from time to time increase or decrease the Maximum Percentage applicable to that Fund to any other percentage not in excess of 19.99%. Any such increase will not be effective until the 61st day after such notice is delivered to the Issuer. As a result of this restriction, the number of shares that may be issued upon exercise of the Prefunded Warrants by the above holders may change depending upon changes in the amount of outstanding shares of Common Stock.

M. Cantey Boyd formerly served on the Board as a representative of the Funds. Ms. Boyd holds 2,500 shares of Common Stock received from the exercise of Stock Options received as director's compensation. The policy of the Funds and the Adviser does not permit employees of the Adviser to receive compensation for serving as directors of the Issuer. Therefore, Ms. Boyd has no pecuniary interest in the Common Stock received from the exercise of Stock Options received as director's compensation for her prior service. The Funds are instead entitled to the pecuniary interest in the Common Stock received from the exercise of Stock Options received as director's compensation for her prior service.

Pursuant to the management agreements, as amended, among the Adviser, the Funds and their respective general partners, the Funds' respective general partners relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds, and thus the Adviser has complete and unlimited discretion and authority with respect to the Funds' investments and voting power over investments.

The Adviser GP is the sole general partner of the Adviser. The Adviser GP, Felix J. Baker and Julian C. Baker as managing members of the Adviser GP, and the Adviser may be deemed to be beneficial owners of securities of the Issuer directly held by the Funds.</amountBeneficiallyOwned>
        <classPercent>The information in Item 11 of each of the cover pages to this Amendment No. 2 is incorporated herein by reference. The percentage of beneficial ownership for each of the Reporting Persons reported herein and the information set forth below is based on 20,693,618 shares of Common Stock outstanding as of September 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 9, 2026 plus 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described above.

Such percentage figures are calculated in accordance with Rule 13d-3 under the Exchange Act.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>The Adviser and the Adviser GP have sole power to vote or direct the vote of 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described above as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd. Julian C. Baker and Felix J. Baker have sole power to vote or direct the vote of 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described above as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd and 113 shares of Common Stock directly held by each of Julian C. Baker and Felix J. Baker.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>The Adviser and the Adviser GP have sole power to dispose or direct the disposition of 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described above as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd. Julian C. Baker and Felix J. Baker have sole power to dispose or direct the disposition of 989,191 shares of Common Stock directly held by the Funds as well as 42,831 shares of Common Stock that may be acquired upon exercise of 42,831 Prefunded Warrants, subject to the limitations on exercise of the Prefunded Warrants as described above as well as 2,500 shares of Common Stock directly held by M. Cantey Boyd and 113 shares of Common Stock directly held by each of Julian C. Baker and Felix J. Baker.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
        <classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>The information in Item 4 is incorporated herein by reference.</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Baker Bros. Advisors LP</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Scott L. Lessing</signature>
        <title>Scott L. Lessing/ President</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Baker Bros. Advisors (GP) LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Scott L. Lessing</signature>
        <title>Scott L. Lessing/ President</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Julian C. Baker</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Julian C. Baker</signature>
        <title>Julian C. Baker</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Felix J. Baker</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Felix J. Baker</signature>
        <title>Felix J. Baker</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
